Compass PathwaysFRA:5Y6 +7.83%40 Market Cap is €1,673.38 Mil as of Jul. 06, 2026. GuruFocus rates FRA:5Y6 with a GF Score™ of 40/100. The stock has 2 warning signs investors should review. Among 692 Healthcare Providers & Services companies, Compass Pathways ranks better than 87.72% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Compass Pathways's share price for the quarter that ended in Mar. 2026 was €4.5. Compass Pathways's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 134.92 Mil. Therefore, Compass Pathways's market cap for the quarter that ended in Mar. 2026 was €607.15 Mil.
Compass Pathways's quarterly market cap
increased
from Sep. 2025 (€484.81 Mil) to Dec. 2025 (€538.08 Mil) and
increased
from Dec. 2025 (€538.08 Mil) to Mar. 2026 (€607.15 Mil).
Compass Pathways's annual market cap
declined
from Dec. 2023 (€501.74 Mil) to Dec. 2024 (€257.76 Mil) but then
increased
from Dec. 2024 (€257.76 Mil) to Dec. 2025 (€538.08 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Compass Pathways's Enterprise Value for Today is €1,312.72 Mil.
Compass Pathways (FRA:5Y6) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Compass Pathways Market Cap Related Terms
Compass Pathways Market Cap Historical Data
* Premium members only.
The historical data trend for Compass Pathways's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Compass Pathways's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Compass Pathways Market Cap vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Compass Pathways's Market Cap distribution charts can be found below:
* The bar in red indicates where Compass Pathways's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Compass Pathways's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Compass Pathways (FRA:5Y6) has a Market Cap of €1,673.38 Mil as of Jul. 06, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Compass Pathways and its competitors. According to the industry distribution chart, Compass Pathways ranks #85 out of 692 companies in the Healthcare Providers & Services industry, placing it in the top 12.3%.
Is Compass Pathways' Market Cap too high?
Compass Pathways' current Market Cap is €1,673.38 Mil. Based on the distribution chart, Compass Pathways ranks #85 out of 692 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Compass Pathways has a GF Score™ of 40/100, reflecting its overall financial health beyond just this single metric.
How does Compass Pathways' Market Cap compare to AGL and MD?
According to the Healthcare Providers & Services industry distribution chart, Compass Pathways ranks #85 out of 692 companies for Market Cap. This places Compass Pathways in the top 12% of its industry — outperforming the majority of peers. The industry median Market Cap is 98.70. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 98.70, based on 692 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Compass Pathways and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 98.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Compass Pathways's current Market Cap is €1,673.38 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Compass Pathways stock overvalued right now?
Compass Pathways (FRA:5Y6) has a current Market Cap of €1,673.38 Mil. The current Market Cap is €1,673.38 Mil. Compass Pathways' overall GF Score™ is 40/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Compass Pathways (FRA:5Y6), the current Market Cap is €1,673.38 Mil as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.
40GF Score
Get the complete analysis for FRA:5Y6
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:5Y6 has been successfully added to your 
